$4.96
Value $2.5B
Clover Health InvestmentsvsMerck & Company
CLOV and MRK stock compared: price, dividend, valuation and results, from SEC filings.
+1.64%
$147.76
Value $365B
Clover Health Investments (CLOV) has a market value of $2.5B and Merck & Company (MRK) $365B. Over the last year, with dividends, CLOV moved +97.6% and MRK +66.3%. The P/E is 204.0 for CLOV and 148.9 for MRK. Dividend yield: CLOV none, MRK 2.30%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
CLOV$2.5B
MRK$365B
MRK is 144 times CLOV
Revenue, 12 months
CLOV$2.7B
MRK$67.4B
MRK is 25 times CLOV
Net income, 12 months
CLOV$12M
MRK$2.5B
MRK is 197 times CLOV
Operating margin
CLOV0.4%
MRK–
ROIC
CLOV2.8%
MRK3.9%
1.1 points apart
P/E
CLOV204.0
MRK148.9
CLOV is 1.4 times MRK
Dividend yield
CLOV0.0%
MRK2.3%
2.3 points apart
5-year return
CLOV-30.7%
MRK+104.9%
135.6 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
CLOV-30.7%
MRK+104.9%
| Period | CLOVWith dividends | MRKWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +97.6%Price +97.6% | +66.3%Price +61.6% |
| 3 years since November 13, 2023 | +451.7%+76.7% a yearPrice +451.7% | +58.0%+16.5% a yearPrice +44.2% |
| 5 years since November 12, 2021 | -30.7%-7.1% a yearPrice -30.7% | +104.9%+15.4% a yearPrice +75.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
CLOVClover Health InvestmentsMRKMerck & Company
Valuation
CLOVMRK| Price | $4.96 | $147.76 |
|---|---|---|
| Market value | $2.5B | $365B |
| Enterprise value (EV) | $2.2B | $409B |
| P/E | 204.0 | 148.9 |
| P/E, 5-year median | – | 14.8 |
| P/B | 6.5 | 8.1 |
| EV/EBIT | 177.7 | 86.0 |
| Free cash flow yield | 5.2% | 4.0% |
Results and growth
CLOVMRK| Revenue, 12 months | $2.7B | $67.4B |
|---|---|---|
| Net income, 12 months | $12M | $2.5B |
| Free cash flow, 12 months | $132M | $14.7B |
| Earnings per share, 12 months | $0.02 | $0.98 |
| Revenue growth, year on year | 40.3% | 1.3% |
| Revenue growth a year, past | +23.4%over 5 years | +9.4%over 5 years |
| EPS growth a year, past | – | +21.2%over 5 years |
Margins and returns on capital
CLOVMRK| Gross margin | – | 71.8% |
|---|---|---|
| Operating margin | 0.4% | – |
| Net margin | 0.4% | 3.6% |
| ROIC | 2.8% | 3.9% |
| ROE | 3.5% | 5.2% |
Balance sheet
CLOVMRK| Cash | $327M | $9.7B |
|---|---|---|
| Total debt | $3.3M | $53.8B |
| Net debt / EBITDA | -22.9 | 5.7 |
| Interest cover | – | 2.4× |
Dividends and buybacks
CLOVMRK| Dividend yield | – | 2.3% |
|---|---|---|
| Dividend per share, 12 months | – | $3.40 |
| Dividend growth a year, past | – | +5.8%over 5 years |
| Buyback yield | 0.7% | 1.4% |
| Shareholder yield | 0.7% | 3.7% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Clover Health Investments or Merck & Company?
By market value, Merck & Company ($365B) is about 143.9 times Clover Health Investments ($2.5B), at today's prices.
How did CLOV and MRK stock do over the last 5 years?
Since November 12, 2021, CLOV's price moved -30.7% and MRK's +75.9%. With dividends: CLOV -30.7% (-7.1% a year), MRK +104.9% (+15.4% a year). Past returns do not predict future ones.
Which pays the higher dividend, CLOV or MRK?
The dividend yield at today's price is none for Clover Health Investments and 2.30% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.
What is the P/E of CLOV and MRK?
At today's price, the P/E is 204.0 for CLOV and 148.9 for MRK. It is the share price over the last twelve months' earnings per share.
Which has the higher profit margins, Clover Health Investments or Merck & Company?
Over the last twelve months, the net margin was 0.4% for Clover Health Investments and 3.6% for Merck & Company, and the operating margin 0.4% and –. Revenue was $2.7B and $67.4B.
Which is the better investment, Clover Health Investments or Merck & Company?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.